The Global Interventional Cardiology And Peripheral Vascular Devices Market was valued at USD 27.7 billion in 2025 and is estimated to grow at a CAGR of 8.2% to reach USD 60.8 billion by 2035.
This growth is fueled by the rising prevalence of vascular diseases worldwide, continuous technological innovations in peripheral vascular devices, increasing adoption of minimally invasive procedures, and growing government healthcare spending to address cardiovascular disease burdens. These devices, including stents, balloons, and catheters, enable healthcare professionals to treat heart and blood vessel conditions without major surgery. Minimally invasive interventions reduce patient recovery time, lower procedural risks, and improve clinical outcomes, making them highly desirable in modern cardiovascular care. Public health initiatives and reimbursement policies further support widespread adoption, making advanced devices more accessible and cost-effective. The combination of innovative device design, regulatory support, and patient preference for safer procedures continues to drive market expansion globally.
The stents segment generated USD 10.4 billion in 2025. Stents, small expandable mesh tubes, restore blood flow in narrowed or blocked arteries and are used in both coronary and peripheral interventions. Their clinical effectiveness, reliability, and continuous design improvements make them the preferred solution for minimally invasive treatments. Drug-eluting stents reduce restenosis and repeat procedures while shortening recovery time compared to traditional surgery, reinforcing their market dominance.
The angioplasty segment reached USD 14.2 billion in 2025 and is expected to grow at a CAGR of 8.3% during 2026-2035. Angioplasty involves inflating a balloon inside an artery to open blocked vessels, often followed by stent placement. It is widely performed for coronary and peripheral artery disease, reducing the need for open-heart surgery and promoting faster patient recovery. Its minimally invasive nature and effectiveness in treating cardiovascular conditions make angioplasty one of the most performed procedures worldwide.
North America Interventional Cardiology and Peripheral Vascular Devices Market held a 28% share in 2025. The region’s market leadership is supported by a high prevalence of cardiovascular conditions, advanced healthcare infrastructure, favorable reimbursement policies, and the early adoption of minimally invasive technologies. Increasing awareness of cardiovascular disease management, technological advancements, and patient preference for less invasive procedures continue to strengthen North America’s dominant market position.
Key players in the Global Interventional Cardiology and Peripheral Vascular Devices Market include Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Cook Medical, Cordis, Endologix, iVascular, Medtronic Plc, Teleflex Inc., Terumo Corporation, and W.L. Gore & Associates, Inc. Companies in the Interventional Cardiology and Peripheral Vascular Devices Market strengthen their position by investing heavily in R&D to enhance device performance, safety, and design. Strategic collaborations with hospitals, research institutions, and technology partners enable the development of next-generation stents, balloons, and catheters. Firms focus on expanding global distribution networks, securing regulatory approvals in new regions, and offering training programs for healthcare providers to increase adoption. Marketing efforts highlight clinical efficacy and procedural benefits to reinforce trust among physicians and patients.
This product will be delivered within 2-4 business days.
This growth is fueled by the rising prevalence of vascular diseases worldwide, continuous technological innovations in peripheral vascular devices, increasing adoption of minimally invasive procedures, and growing government healthcare spending to address cardiovascular disease burdens. These devices, including stents, balloons, and catheters, enable healthcare professionals to treat heart and blood vessel conditions without major surgery. Minimally invasive interventions reduce patient recovery time, lower procedural risks, and improve clinical outcomes, making them highly desirable in modern cardiovascular care. Public health initiatives and reimbursement policies further support widespread adoption, making advanced devices more accessible and cost-effective. The combination of innovative device design, regulatory support, and patient preference for safer procedures continues to drive market expansion globally.
The stents segment generated USD 10.4 billion in 2025. Stents, small expandable mesh tubes, restore blood flow in narrowed or blocked arteries and are used in both coronary and peripheral interventions. Their clinical effectiveness, reliability, and continuous design improvements make them the preferred solution for minimally invasive treatments. Drug-eluting stents reduce restenosis and repeat procedures while shortening recovery time compared to traditional surgery, reinforcing their market dominance.
The angioplasty segment reached USD 14.2 billion in 2025 and is expected to grow at a CAGR of 8.3% during 2026-2035. Angioplasty involves inflating a balloon inside an artery to open blocked vessels, often followed by stent placement. It is widely performed for coronary and peripheral artery disease, reducing the need for open-heart surgery and promoting faster patient recovery. Its minimally invasive nature and effectiveness in treating cardiovascular conditions make angioplasty one of the most performed procedures worldwide.
North America Interventional Cardiology and Peripheral Vascular Devices Market held a 28% share in 2025. The region’s market leadership is supported by a high prevalence of cardiovascular conditions, advanced healthcare infrastructure, favorable reimbursement policies, and the early adoption of minimally invasive technologies. Increasing awareness of cardiovascular disease management, technological advancements, and patient preference for less invasive procedures continue to strengthen North America’s dominant market position.
Key players in the Global Interventional Cardiology and Peripheral Vascular Devices Market include Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Cook Medical, Cordis, Endologix, iVascular, Medtronic Plc, Teleflex Inc., Terumo Corporation, and W.L. Gore & Associates, Inc. Companies in the Interventional Cardiology and Peripheral Vascular Devices Market strengthen their position by investing heavily in R&D to enhance device performance, safety, and design. Strategic collaborations with hospitals, research institutions, and technology partners enable the development of next-generation stents, balloons, and catheters. Firms focus on expanding global distribution networks, securing regulatory approvals in new regions, and offering training programs for healthcare providers to increase adoption. Marketing efforts highlight clinical efficacy and procedural benefits to reinforce trust among physicians and patients.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Interventional Cardiology and Peripheral Vascular Devices market report include:- Abbott Laboratories
- AngioDynamics
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health
- Cook Medical
- Cordis
- Endologix
- iVascular
- Medtronic Plc
- Teleflex Inc.
- Terumo Corporation
- W.L. Gore & Associates, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | February 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 27.7 Billion |
| Forecasted Market Value ( USD | $ 60.8 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
